Cargando…

Circulating PCSK9 levels and 2-hPG are positively correlated in metabolic diseases in a Chinese Han population

BACKGROUND: Proprotein convertase subtilisin/kexin type 9 (PCSK9), which plays a crucial role in lipoprotein metabolism, has been also regarded as an important marker for atherosclerosis. Available evidence indicated that 2-h postchallenge plasma glucose (2-hPG) could be another biomarker for athero...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Wen, Gong, Yingyun, Gu, Yong, Fu, Zhenzhen, Fan, Hongqi, Gao, Beibei, Zhu, Xiaohui, Fu, Jinxiang, Zhao, Yang, Sun, Min, Liu, Xing, Jiang, Xian-Cheng, Yang, Tao, Zhou, Hongwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772698/ https://www.ncbi.nlm.nih.gov/pubmed/29343301 http://dx.doi.org/10.1186/s12944-018-0658-z

Ejemplares similares

Prognostic Value of Plasma hPG(80) (Circulating Progastrin) in Metastatic Renal Cell Carcinoma
por: Kohli, Manish, et al.
Publicado: (2021)

Plasma hPG(80) (Circulating Progastrin) as a Novel Prognostic Biomarker for Hepatocellular Carcinoma
por: Dupuy, Marie, et al.
Publicado: (2022)

Inactivation of the lysine binding sites of human plasminogen (hPg) reveals novel structural requirements for the tight hPg conformation, M-protein binding, and rapid activation
por: Ayinuola, Yetunde A., et al.
Publicado: (2023)

Association between post-operative hPG(80) (circulating progastrin) detectable level and worse prognosis in glioblastoma
por: Doucet, L., et al.
Publicado: (2023)

hPG(80) (circulating progastrin) as a blood biomarker for high-grade glial tumors: A pilot study
por: Casile, Melanie, et al.
Publicado: (2023)

The positive association of branched-chain amino acids and metabolic dyslipidemia in Chinese Han population
por: Yang, Panpan, et al.
Publicado: (2016)

The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients
por: You, Benoit, et al.
Publicado: (2019)

The effect of cholesteryl ester transfer protein on pancreatic beta cell dysfunction in mice
por: Guo, Wen, et al.
Publicado: (2016)

Serum PCSK9 levels, but not PCSK9 polymorphisms, are associated with CAD risk and lipid profiles in southern Chinese Han population
por: Cai, Gaojun, et al.
Publicado: (2018)

Plasma hPG(80) (Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort
por: Prieur, Alexandre, et al.
Publicado: (2023)

hPG(80) (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors
por: Chauhan, Aman, et al.
Publicado: (2022)

Relationship between Branched-Chain Amino Acids, Metabolic Syndrome, and Cardiovascular Risk Profile in a Chinese Population: A Cross-Sectional Study
por: Hu, Wen, et al.
Publicado: (2016)

A Comparison of hs-CRP Levels in New Diabetes Groups Diagnosed Based on FPG, 2-hPG, or HbA1c Criteria
por: Tutuncu, Yildiz, et al.
Publicado: (2016)

Lipid Lowering Therapy and Circulating PCSK9 Concentration
por: Nozue, Tsuyoshi
Publicado: (2017)

Circulating PCSK9 Linked to Dyslipidemia in Lebanese Schoolchildren
por: Azar, Yara, et al.
Publicado: (2022)

PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells
por: Lagace, Thomas A.
Publicado: (2014)

The predictive utility of circulating PCSK9 levels on diabetes mellitus
por: Peng, Jia, et al.
Publicado: (2021)

Sex difference in circulating PCSK9 and its clinical implications
por: Jia, Fang, et al.
Publicado: (2022)

The R93C Variant of PCSK9 Reduces the Risk of Premature MI in a Chinese Han Population
por: Yang, Lincheng, et al.
Publicado: (2022)

Correlation of PCSK9 Gene Polymorphism with Cerebral Ischemic Stroke in Xinjiang Han and Uygur Populations
por: Han, Dengfeng, et al.
Publicado: (2014)

Circulating PCSK9 Level and Risk of Cardiovascular Events and Death in Hemodialysis Patients
por: Hwang, Hyeon Seok, et al.
Publicado: (2020)

Circulating PCSK9 and Risk of Myocardial Infarction: The HUNT Study in Norway
por: Laugsand, Lars E., et al.
Publicado: (2016)

Insulin-Like Factor 3 and the HPG Axis in the Male
por: Ivell, Richard, et al.
Publicado: (2014)

Sex Differences Associated With Circulating PCSK9 in Patients Presenting With Acute Myocardial Infarction
por: Zhang, Zhong, et al.
Publicado: (2019)

Structural comparison of somatically related PG9 and PG16 in complex with their epitope reveals differences in glycan recognition
por: Pancera, M, et al.
Publicado: (2012)

Correlation Between Circulating PCSK9 Levels and Gestational Diabetes Mellitus in a Chinese Population
por: Wu, Yiming, et al.
Publicado: (2022)

Circulating Mature PCSK9 Level Predicts Diminished Response to Statin Therapy
por: Kuyama, Naoto, et al.
Publicado: (2021)

Relationship between Circulating PCSK9 and Markers of Subclinical Atherosclerosis—The IMPROVE Study
por: Coggi, Daniela, et al.
Publicado: (2021)

Cross-group neutralization of HIV-1 and evidence for conservation of the PG9/PG16 epitopes within divergent groups of HIV-1
por: Braibant, M, et al.
Publicado: (2012)

Effects of estradiol and FSH on maturation of the testis in the hypogonadal (hpg) mouse
por: Baines, Helen, et al.
Publicado: (2008)

HPG pore: an efficient and scalable framework for nanopore sequencing data
por: Tarraga, Joaquin, et al.
Publicado: (2016)

HPG-DHunter: an ultrafast, friendly tool for DMR detection and visualization
por: Fernández, Lisardo, et al.
Publicado: (2020)

HPG-Dependent Peri-Pubertal Regulation of Adult Neurogenesis in Mice
por: Trova, Sara, et al.
Publicado: (2020)

The Family Biorhythm: Contributions of the HPA and HPG Axes to Neuroendocrine Attunement
por: Wood, Erin E., et al.
Publicado: (2023)

FOURIER & PCSK9 RNAi: Towards enhancing durability and efficacy of PCSK9 inhibitors
por: Hassan, Mohamed
Publicado: (2017)

The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol
por: Seidah, Nabil G.
Publicado: (2017)

The Multifaceted Biology of PCSK9
por: Seidah, Nabil G, et al.
Publicado: (2021)

The association between circulatory, local pancreatic PCSK9 and type 2 diabetes mellitus: The effects of antidiabetic drugs on PCSK9
por: Lu, Fengyuan, et al.
Publicado: (2023)

Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy
por: Cao, Ye-Xuan, et al.
Publicado: (2019)

Study on the Mechanism of Sarsasapogenin in Treating Precocious Puberty by Regulating the HPG Axis
por: Hu, Kaili, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tc1t9o5b5sr3l41q76d7av775m